Rheumatoid arthritis is caused by a Proteus urinary tract infection

APMIS

Volumn 122, Issue 5, 2014, Pages 363-368

  Ebringer, Alan ^a   Rashid, Taha ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Proteus; Rheumatoid arthritis; Urinary tract infection

Indexed keywords

ANTIBIOTIC AGENT; ARGININE; ARGININE DEIMINASE; AUTOANTIBODY; BACTERIAL TOXIN; BACTERIUM ANTIBODY; BIOLOGICAL PRODUCT; CHEMOKINE; CROSS REACTING ANTIBODY; FIBRIN; FILAGGRIN; HEMOLYSIN; HLA DR1 ANTIGEN; HLA DR4 ANTIGEN; HLA DRB1 ANTIGEN; METHOTREXATE; PROTEIN ANTIBODY;

AMINO ACID SEQUENCE; ANTIBIOTIC THERAPY; ANTIBODY TITER; CROSS REACTION; ESCHERICHIA COLI; GENETIC ANALYSIS; HUMAN; HYALINE CARTILAGE; LYMPH NODE; LYMPHOCYTE; MACROPHAGE; MOLECULAR MIMICRY; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; PROTEUS; PROTEUS INFECTION; PROTEUS MIRABILIS; PROTEUS VULGARIS; REVIEW; RHEUMATIC FEVER; RHEUMATOID ARTHRITIS; SYNOVIUM; URINARY TRACT; URINARY TRACT INFECTION;

PROTEUS; RHEUMATOID ARTHRITIS; URINARY TRACT INFECTION;

ANTIBODIES, BACTERIAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CHONDROCYTES; CROSS REACTIONS; HLA-DR1 ANTIGEN; HUMANS; LYMPH NODES; PROTEUS INFECTIONS; PROTEUS MIRABILIS; URINARY TRACT INFECTIONS;

EID: 84899491444     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12154     Document Type: Review

References (47)

1. Sweeney SE, Harris ED Jr, Firestein GS. Clinical features of rheumatoid arthritis. In: Firestein GS, Budd RC, Gabriel SE, O'Dell JR, editors. Kelley's Textbook of Rheumatology. Philadelphia: Elsvier Health Sciences, 2012: 1109-37.
2. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. New Engl J Med 1978;298:869-71.
3. Schiff B, Mizrachi Y, Orgad S, Yaron M, Gazit E. Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis 1982;41:403-4.
4. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
5. Wilson C, Ebringer A, Ahmadi K, Wrigglesworth J, Tiwana H, Fielder M, et al. Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis. Ann Rheum Dis 1995;54:216-20.
6. Cunningham MW. Streptococcus and rheumatic fever. Curr Opin Rheumatol 2012;24:408-16.
7. Ebringer A, Ptazynska T, Corbett M, Wilson C, Macafee Y, Avakian H, et al. Antibodies to Proteus in rheumatoid arthritis. Lancet 1985;2:305-7.
8. Law H, Fiadjoi P. Urogynaecological problems in pregnancy. J Obstet Gynaecol 2012;32:109-12.
9. Ebringer A. Rheumatoid arthritis and Proteus. London: Springer, 2012.
10. Wilson C, Rashid T, Tiwana H, Beyan H, Hughes L, Bansal S, et al. Cytotoxicity responses to peptide antigens in rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 2003;30:972-8.
11. Blankenberg-Sprenkels SH, Fielder M, Feldkamp TE, Tiwana H, Wilson C, Ebringer A. Antibodies to Klebsiella pneumonia in Dutch patients with ankylosing spondylitis and uveitis and to Proteus mirabilis in rheumatoid arthritis. J Rheumatol 1998;25:743-7.
12. Tani Y, Tiwana H, Hukuda S, Nishioka J, Fielder M, Wilson C, et al. Antibodies to Klebsiella, Proteus and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 1997;24:109-14.
13. Inglis TJ. Principia aetiologica: taking causality beyond Koch's postulates. J Med Microbiol 2007;56:1419-22.
14. Lawson AA, Maclean N. Renal disease and drug therapy in rheumatoid arthritis. Ann Rheum Dis 1966;25:441-9.
15. Tishler M, Caspi D, Aimog Y, Segal R, Yaron M. Increased incidence of urinary tract infection in patients with rheumatoid arthritis and secondary Sjogren's syndrome. Ann Rheum Dis 1992;51:601-6.
16. Wilson C, Thakore D, Isenberg D, Ebringer A. Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis. Rheumatol Int 1997;16:187-9.
17. Senior BW, Anderson GA, Morley KD, Kerr MA. Evidence that patients with rheumatoid arthritis have asymptomatic 'non-significant' Proteus mirabilis bacteriuria more frequently than healthy controls. J Infect 1999;38:99-106.
18. Rashid T, Ebringer A. Rheumatoid arthritis is caused by asymptomatic Proteus urinary tract infections. In: Nikibakhsh AA, editor. Clinical Management of Complicated Urinary Tract Infection. Rijeka: InTech, 2011: 171-80.
19. Fairley KF, Carson NE, Gutch RC, Leighton P, Grounds AD, Laird EC, et al. Site of infection in acute urinary tract infection in general practice. Lancet 1971; 2:615-8.
20. Hooton TM. Clinical practice. Uncomplicated urinary tract infection. New Engl J Med 2012; 366:1028-37.
21. Galloway JB, Mercer LK, Moseley A, Dixon WG, Ustianowski AP, Helbert M, et al. Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2013;72:229-34.
22. Silva F, Seo P, Schroeder DR, Stone JH, Merkel PA, Hoffman GS, et al. Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicentre longitudinal cohort. Arthritis Rheum 2011;63:2495-503.
23. Wasfi R, Abd El-Rahman OA, Mansour LE, Hanora AS, Hashem AM, Ashour MS. Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections. Indian J Med Microbiol 2012;30:76-80.
24. Wang CH, Fang CC, Chen NC, Liu SS, Yu PH, Wu TY, et al. Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2012;171:988-96.
25. Jacobs JW. Lessons for the use of non-biologic anchor treatments for rheumatoid arthritis in the era of biologic therapies. Rheumatology (Oxford) 2012;51(Suppl. 4):27-33.
26. Malaviya AP, Ostor AJ. Rheumatoid arthritis and the era of biologic therapy. Inflammopharmacology 2012;20:59-69.
27. Nicaise-Roland P, Nogueira L, Demattei C, de Chaisemartin L, Rincheval N, Cornillet M, et al. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort. Ann Rheum Dis 2013;72:357-62.
28. Luban S, Li ZG. Citrullinated peptide and its relevance to rheumatoid arthritis: an update. Int J Rheum Dis 2010;13:284-7.
29. Sanmarti R, Graell E, Perez ML, Ercilla G, Vinas O, Gomez-Puerta JA, et al. Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis. Arthritis Res Ther 2009;11:135.
30. Abuljadayel I, Cox N, Ebringer A. Antibodies to Proteus in rheumatoid arthritis (RA) and to Klebsiella in ankylosing spondylitis (AS) measured by immunofluorescence. Br J Rheumatol 1988; 27 (Suppl 2), Abstract 3: 2.
31. Deighton CM, Gray SW, Biant AJ, Walker DJ. Anti-Proteus antibodies in rheumatoid arthritis same-sexed sibships. Br J Rheumatol 1992;31:241-5.
32. Subair H, Tiwana H, Fielder M, Binder A, Cunningham K, Ebringer A, et al. Elevation in anti-Proteus antibodies in patients with rheumatoid arthritis from Bermuda and England. J Rheumatol 1995;22:1825-8.
33. Tiwana H, Wilson C, Cunningham P, Binder A, Ebringer A. Antibodies to four gram-negative bacteria in rheumatoid arthritis which share sequences with the rheumatoid arthritis susceptibility motif. Br J Rheumatol 1996;35:592-4.
34. Tiwana H, Wilson C, Walmsley RS, Wakefield AJ, Smith MS, Cox NL, et al. Antibody response to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis. Rheumatol Int 1997;17:11-6.
35. Rashid T, Darlington G, Kjeldsen-Kragh J, Forre O, Collado A, Ebringer A. Proteus IgG antibodies and C-reactive protein in English, Norwegian and Spanish patients with rheumatoid arthritis. Clin Rheumatol 1999;18:190-5.
36. Rogers P, Hassan J, Bresnihan B, Feighery C, Whelan A. Antibodies to Proteus in rheumatoid arthritis. Br J Rheumatol 1988;27(Suppl 2):90-4.
37. Fielder M, Youinou P, Cantagrel A, Wilson C, Ebringer A. Elevation of anti-Proteus antibody titres in rheumatoid arthritis patients from Brest and Toulouse measured by immunofluorescence. Clin Exp Rheumatol 1994;12(Suppl 2): S104:Abstract C125.
38. Fielder M, Tiwana H, Youinou P, Le Goff P, Deonarain R, Wilson C, et al. The specificity of the anti-Proteus antibody response in tissue-typed rheumatoid arthritis (RA) patients from Brest. Rheumatol Int 1995;15:79-82.
39. Senior BW, McBride PDP, Morley KD, Kerr MA. The detection of raised levels of IgM to Proteus mirabilis in sera from patients with rheumatoid arthritis. J Med Microbiol 1995;43:176-84.
40. Kjeldsen-Kragh J, Rashid T, Dybwad A, Sioud M, Haugen M, Forre O, et al. Decrease in anti-Proteus mirabilis but not anti-Escherichia coli antibody levels in rheumatoid arthritis patients treated with fasting and a one year vegetarian diet. Ann Rheum Dis 1995;54:221-4.
41. Wanchu A, Deodhar SD, Sharma M, Gupta V, Bambery P, Sud A. Elevated levels of anti-Proteus antibodies in patients with active rheumatoid arthritis. Indian J Med Res 1997;105:39-42.
42. Chou CT, Uksila J, Toivanen P. Enterobacterial antibodies in Chinese patients with rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 1998;16:161-4.
43. Ushakova MA, Muravijuv UV, Vaneeva NP, Jastrebova NE, Maslov II, Zacharova IE, et al. The Proteus mirabilis antibody levels in patients with rheumatoid arthritis. Rheumatologia 2000;14:Abstract: 78.
44. Rashid T, Leirisalo-Repo M, Tani Y, Hukuda S, Kobayashi S, Wilson C, et al. Antibacterial and antipeptide antibodies in Japanese and Finnish patients with rheumatoid arthritis. Clin Rheumatol 2004;23:134-41.
45. Newkirk MM, Goldbach-Mansky R, Senior BW, Klippel J, Schumacher HR Jr, El-Gabalawy HS. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Rheumatology 2005;44:1433-41.
46. Rashid T, Jayakumar KS, Binder A, Ellis S, Cunningham P, Ebringer A. Rheumatoid arthritis patients have elevated antibodies to cross-reactive and non cross-reactive antigens from Proteus microbes. Clin Exp Rheumatol 2007;25:259-67.
47. Konieczna I, Kwinkowski M, Kolesinska B, Kaminski Z, Fraczyk J, Zarnowiec P, et al. Detection of antibodies against synthetic peptides mimicking ureases fragments in sera of rheumatoid arthritis patients. Protein Pept Lett 2012;19:1149-54.